[Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].

Stella H AkmanJohanna M PfeilAndreas StahlStephanie EhlersCarolin BöhneBettina BohnhorstCarsten FrammeDorothee BrockmannAnna BajorChristina JacobsenKarsten HufendiekAmelie Pielennull null

Published in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (2021)

This is the first monocentric analysis over 15 years originating from the Retina.net ROP registry. In this cohort we see a change in ROP therapy from laser coagulation to anti-VEGF (bevacizumab) from 2014 onwards, demographic data and treatment parameters remained relatively stable over time.

Keyphrases

electronic health record
diabetic retinopathy
big data
endothelial cells
stem cells
machine learning
mass spectrometry
bone marrow
replacement therapy
deep learning
cell therapy
high speed